ProfileGDS4718 / 207064_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 22% 23% 25% 25% 27% 25% 28% 22% 27% 31% 27% 26% 30% 29% 28% 25% 25% 28% 31% 21% 24% 25% 27% 25% 26% 27% 26% 25% 28% 30% 26% 29% 25% 26% 27% 31% 32% 24% 25% 28% 22% 31% 22% 32% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2281122
GSM549102patient 115, normal, homogenized [OPG study]4.2753123
GSM549104patient 119, normal, homogenized [OPG study]4.330525
GSM549108patient 138, normal, homogenized [OPG study]4.3685725
GSM549119patient 077, normal, homogenized [OPG study]4.4169827
GSM549133patient 032, cancer, homogenized [OPG study]4.2797325
GSM549139patient 042, cancer, homogenized [OPG study]4.4568928
GSM549099patient 107, normal, homogenized [OPG study]4.2339822
GSM549109patient 139, normal, homogenized [OPG study]4.4494727
GSM549110patient 046, normal, homogenized [OPG study]4.5906531
GSM549114patient 063, normal, homogenized [OPG study]4.3806627
GSM549122patient 082, normal, homogenized [OPG study]4.3694526
GSM549134patient 033, cancer, homogenized [OPG study]4.5436630
GSM549136patient 036, cancer, homogenized [OPG study]4.4485129
GSM549140patient 044, cancer, homogenized [OPG study]4.4019528
GSM549111patient 047, normal, homogenized [OPG study]4.3231525
GSM549113patient 057, normal, homogenized [OPG study]4.2993325
GSM549132patient 031, cancer, homogenized [OPG study]4.4380628
GSM549137patient 038, cancer, homogenized [OPG study]4.5472131
GSM549142patient 047, cancer, homogenized [OPG study]4.2858721
GSM549100patient 110, normal, homogenized [OPG study]4.3264924
GSM549107patient 135, normal, homogenized [OPG study]4.3198125
GSM549115patient 068, normal, homogenized [OPG study]4.3594227
GSM549116patient 072, normal, homogenized [OPG study]4.3195325
GSM549120patient 078, normal, homogenized [OPG study]4.3739326
GSM549131patient 030, cancer, homogenized [OPG study]4.3839927
GSM549118patient 074, normal, homogenized [OPG study]4.3893326
GSM549129patient 027, cancer, homogenized [OPG study]4.3687625
GSM549123patient 088, normal, homogenized [OPG study]4.4566628
GSM549124patient 006, cancer, homogenized [OPG study]4.5958130
GSM549126patient 015, cancer, homogenized [OPG study]4.3828426
GSM549128patient 025, cancer, homogenized [OPG study]4.4901229
GSM549103patient 117, normal, homogenized [OPG study]4.378625
GSM549117patient 073, normal, homogenized [OPG study]4.3656226
GSM549138patient 041, cancer, homogenized [OPG study]4.4083927
GSM549141patient 045, cancer, homogenized [OPG study]4.5012731
GSM549130patient 028, cancer, homogenized [OPG study]4.6364532
GSM549101patient 111, normal, homogenized [OPG study]4.3246724
GSM549105patient 128, normal, homogenized [OPG study]4.3657625
GSM549106patient 134, normal, homogenized [OPG study]4.4007328
GSM549112patient 048, normal, homogenized [OPG study]4.2084322
GSM549125patient 011, cancer, homogenized [OPG study]4.5879931
GSM549127patient 024, cancer, homogenized [OPG study]4.2175122
GSM549135patient 035, cancer, homogenized [OPG study]4.5672632